UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The tubal epigenome – An emerging target for ovarian cancer

Pharmacology & therapeutics (Oxford), 2020-06, Vol.210, p.107524-107524, Article 107524

2020

Volltextzugriff (PDF)

The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Clinical cancer research, 2019-10, Vol.25 (20), p.6127-6140

2019

Volltextzugriff (PDF)

Tumor Innervation: Cancer Has Some Nerve

Trends in Cancer, 2020-12, Vol.6 (12), p.1059-1067

2020

Volltextzugriff (PDF)

MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity

Cell reports (Cambridge), 2021-03, Vol.34 (9), p.108808-108808, Article 108808

2021

Volltextzugriff (PDF)

Quantitative, Point-of-Care Immunoassay Platform to Guide and Monitor Sickle Cell Disease Therapy

Analytical chemistry (Washington), 2016-08, Vol.88 (16), p.7904-7909

2016

Volltextzugriff (PDF)

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary

Communications biology, 2022-12, Vol.5 (1), p.1362-17, Article 1362

2022

Volltextzugriff (PDF)

Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells

JCI insight, 2024-01, Vol.9 (5)

2024

Volltextzugriff (PDF)

NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair

Cell death discovery, 2018-12, Vol.4 (1), p.10-12, Article 10

2018

Volltextzugriff (PDF)

Norepinephrine promotes anoikis resistance in fallopian tube secretory cells through beta adrenergic receptor signaling (247)

Gynecologic oncology, 2022-08, Vol.166, p.S134

2022

Volltextzugriff (PDF)

H2Bub1: Guardian of chromatin accessibility in ovarian cancer

Oncoscience, 2019-08, Vol.6 (7-8), p.349-350

2019

Volltextzugriff (PDF)

Abstract 4287: Whole-genome CRISPR/Cas9 screen of the CHK1 inhibitor prexasertib implicates FAM122A loss as a potential resistance mechanism

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4287-4287

2018

Volltextzugriff (PDF)

Abstract PR006: Infiltration of TRPV1+ nerves influences the ovarian cancer immune landscape

Cancer research (Chicago, Ill.), 2021-03, Vol.81 (5_Supplement), p.PR006-PR006

2021

Volltextzugriff (PDF)

Abstract 4071: Utilizing colforsin as a novel therapeutic for high grade serous ovarian cancer treatment

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.4071-4071

2022

Volltextzugriff (PDF)

Investigating the Relationship Between the Nervous System and High-Grade Serous Ovarian Cancer

Reavis, Hunter Danielle

2023

Volltextzugriff (PDF)

Abstract A088: Tumor innervation as a novel driver of ovarian cancer progression

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_2), p.A088-A088

2024

Volltextzugriff (PDF)

Abstract 4189: Homologous recombination pathway-based biomarkers for treatment of non-small cell lung cancer with PARP inhibitors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4189-4189

2017

Volltextzugriff (PDF)

Abstract 1620: ATR inhibition for the treatment of ATM-deficient gastric cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1620-1620

2018

Volltextzugriff (PDF)

Abstract IA004: Fallopian tube cancer precursors sculpt the tumor microenvironment in novel ways

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_2), p.IA004-IA004

2024

Volltextzugriff (PDF)

Abstract 2922: Sensory innervation as a novel driver of ovarian cancer progression

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2922-2922

2024

Volltextzugriff (PDF)

Functional neuronal circuits promote disease progression in cancer

Science advances, 2023-05, Vol.9 (19), p.eade4443-eade4443

2023

Volltextzugriff (PDF)

Abstract 2796: Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2796-2796

2017

Volltextzugriff (PDF)

Efficacy of Transoral Fundoplication vs Omeprazole for Treatment of Regurgitation in a Randomized Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2015-02, Vol.148 (2), p.324-333.e5

2015

Volltextzugriff (PDF)

Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms

Annals of surgery, 2004-06, Vol.239 (6), p.849-858

2004

Volltextzugriff (PDF)

Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses

Annals of surgery, 2005-05, Vol.241 (5), p.736-747

2005

Volltextzugriff (PDF)

Transoral Fundoplication Provides Better GERD Symptom Control Than PPIs in Patients With Troublesome Regurgitation: A Multicenter Sham-Controlled Randomized Clinical Trial: 32

The American journal of gastroenterology, 2014-10, Vol.109, p.S13

2014

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The tubal epigenome – An emerging target for ovarian cancer

The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition

Tumor Innervation: Cancer Has Some Nerve

MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity

Quantitative, Point-of-Care Immunoassay Platform to Guide and Monitor Sickle Cell Disease Therapy

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary

Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells

NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair

Norepinephrine promotes anoikis resistance in fallopian tube secretory cells through beta adrenergic receptor signaling (247)

H2Bub1: Guardian of chromatin accessibility in ovarian cancer

Abstract 4287: Whole-genome CRISPR/Cas9 screen of the CHK1 inhibitor prexasertib implicates FAM122A loss as a potential resistance mechanism

Abstract PR006: Infiltration of TRPV1+ nerves influences the ovarian cancer immune landscape

Abstract 4071: Utilizing colforsin as a novel therapeutic for high grade serous ovarian cancer treatment

Investigating the Relationship Between the Nervous System and High-Grade Serous Ovarian Cancer

Abstract A088: Tumor innervation as a novel driver of ovarian cancer progression

Abstract 4189: Homologous recombination pathway-based biomarkers for treatment of non-small cell lung cancer with PARP inhibitors

Abstract 1620: ATR inhibition for the treatment of ATM-deficient gastric cancer

Abstract IA004: Fallopian tube cancer precursors sculpt the tumor microenvironment in novel ways

Abstract 2922: Sensory innervation as a novel driver of ovarian cancer progression

Functional neuronal circuits promote disease progression in cancer

Abstract 2796: Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity

Efficacy of Transoral Fundoplication vs Omeprazole for Treatment of Regurgitation in a Randomized Controlled Trial

Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms

Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses

Transoral Fundoplication Provides Better GERD Symptom Control Than PPIs in Patients With Troublesome Regurgitation: A Multicenter Sham-Controlled Randomized Clinical Trial: 32

Suchergebnisse filtern